Analyst Ratings For Proteome Sciences plc (LON:PRM)
Today, FinnCap reiterated its Corporate rating on Proteome Sciences plc (LON:PRM) with a price target of GBX 12.
There are no ratings tracked in the last 12 months. on the stock.
The current consensus rating on Proteome Sciences plc (LON:PRM) is N/A (Score: NaN) with a consensus target price of GBX 12 per share, a potential .
Some recent analyst ratings include
- 2/24/2017-FinnCap Reiterated Rating of Corporate.
About Proteome Sciences plc (LON:PRM)
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.
Recent Trading Activity for Proteome Sciences plc (LON:PRM)
Shares of Proteome Sciences plc closed the previous trading session at 4.61 down -0.03 -0.75% with 0 shares trading hands.